Cor Therapeutics

Glycoprotein IIb/IIIa inhibitors fro the treatment of cardiovascular diseases.

placeSan Francisco, California, United States calendar_todayFounded 1988 language corr.com

Investor mix

1 investor on record.

Investor typeCountShare
Private equity1100%
Coming soon